Revolutionary Heart Patch Offers Hope for Patients with Heart Failure
In a significant advancement for cardiac medicine, researchers have developed a pioneering implantable heart patch aimed at treating patients suffering from advanced heart failure. This innovative solution utilizes cells from blood that are reprogrammed to function as heart muscle cells, potentially revitalizing damaged hearts.
Heart failure currently impacts over 64 million individuals globally, leading to a pressing need for effective treatment alternatives. Traditional options, such as heart transplants and artificial pumps, are limited by organ availability, high costs, and associated complications. The newly engineered patches could bridge this gap by providing a biological transplant that supports the heart's functionality.
Prof. Ingo Kutschka from University Medical Center Göttingen in Germany, a co-author of the study published in the journal Nature, states, “We now have, for the first time, a laboratory-grown biological transplant available, which has the potential to stabilize and strengthen the heart muscle.”
The patches are constructed from heart muscle and connective tissue cells grown in a collagen gel, designed to be attached in arrays to a membrane about 5cm by 10cm in size. Testing in healthy rhesus macaques showed promising results, with no observed adverse effects, such as irregular heartbeats or tumors, after six months.
The patches were also tested on a 46-year-old woman with advanced heart failure, where they were sutured onto her heart during minimally invasive surgery. Positive responses were noted, and the patches maintained viability even after a subsequent heart transplant.
While therapeutic effects from the patches can take three to six months to manifest, making them unsuitable for all patients, 15 individuals have already been treated. The researchers express hope that ongoing clinical trials will confirm the patches’ ability to enhance cardiac function.
Experts in the field, including Prof. Sian Harding from Imperial College London, have hailed the research as groundbreaking, suggesting it may offer new avenues for patients who currently face high mortality rates.
Weekly Newsletter
News summary by melangenews